HOME
HIV and AIDS
Hepatitis B
Hepatitis C
HIV-HCV Coinfection
HIV-HBV Coinfection
HIV and AIDS Articles on:
  FDA-approved Treatments
 
Experimental Treatments
 
Top New Articles
HOME PAGE

Adverse Events
Anemia | Liver Toxicity / Depression / Neuropathy
Kidney Toxicity / Kidney Stones
CNS / Bone Disorders / Malignancies and Cancers

Women and Men Respond Similarly to Antiretroviral Drugs and Experience Comparable Side Effects: GRACE, M05-730, CASTLE, ARTEM - 8/19/2008

Pregabalin vs Placebo for the Treatment of Painful HIV-associated Peripheral Neuropathy - 8/15/2008

Study Presentation Overstates Tenofovir Kidney Toxicity Risk - 8/15/2008

What is the Risk of Kidney Toxicity Associated with Tenofovir (Viread)? - 8/12/08


What is the Risk of Kidney Toxicity Associated with Tenofovir (Viread)? - 8/12/08

African American HIV Patients Experience More Aggressive Kidney Disease Progression - 7/22/08

Incidence of Anal Cancer in People with HIV Continues to Rise despite HAART - 7/15/08

HAART Is Equally Protective against First AIDS-defining Cancers and Other First AIDS-defining Events - 7/18/08

Incidence of Anal Cancer in People with HIV Continues to Rise despite HAART - 7/15/08

Kaposi Sarcoma (KS) in HIV Negative Men Who Have Sex with Men - 6/24/08

High-concentration Capsaicin Patch Is Beneficial for Treatment of Painful HIV-related Neuropathy - 6/17/08


FDA and European Medicines Agency Will Consider New Biomarker Test Results When Assessing Kidney Toxicity of Experimental Drugs - 6/17/08

HAART Regimen Changes Due to Drug Toxicities in HIV Positive People with Virological Suppression - 6/13/08

Long-term Alcohol Abuse Is Linked to Worse Liver Fibrosis in HIV Positive Veterans with or without HCV Coinfection
- 6/03/08

Large Study Finds Several Types of Non-AIDS-defining Cancer Are More Common in HIV Positive People - 5/30/08

Gastrointestinal Symptoms Are Uncommon during Early HIV Infection, Despite CD4 Cell Depletion in the Gut - 5/23/08

Inflammatory Bowel Disease in HIV Positive Individuals - 5/23/08

Does Tenofovir (Viread) Increase Liver Toxicity Related to Efavirenz (Sustiva)? - 5/16/08

Treatment Options for Osteopenia and Osteoporosis in HIV Patients - 5/02/08

HLA B*5701 Genetic Test Predicts Abacavir Hypersensitivity in Black as well as White HIV Patients - 5/02/08

Elevated Fibrinogen Levels Linked to Protease Inhibitors May Contribute to Elevated Cardiovascular Risk  - 4/15/08

Management of HIV Positive Men with Prostate Cancer in the HAART Era  - 4/11/08

Prevalence and Outcomes of Liver Cirrhosis in HIV Positive People  - 4/11/08

HAART Appears to Halt HIV-related Brain Damage in HIV Patients
- 10/12/07

Non-AIDS-defining Illnesses and Cancers in the HAART Era - 10/05/07

Appearance of HIV-related Kaposi's Sarcoma (KS) in Older HIV Patients with a High CD4 Count and a Low Viral Load - 10/02/07

Chronic Kidney Disease in People with HIV - 10/02/07

Lopinavir-ritonavir (Kaletra) Dramatically Affects the Pharmacokinetics of the Anti-cancer Agent Irinotecan (Camptosar) in HIV Patients with Kaposi's Sarcoma - 8/28/07

Neurocognitive Problems in People with HIV May Persist Despite HAART    - 7/07/07

Liver Toxicity among HIV Positive African Patients on HAART Is Associated with Tuberculosis Therapy and Hepatitis B Coinfection    - 7/07/07

Kidney Stones are a Possible, but Uncommon, Side Effect of Atazanavir (Reyataz)    - 6/22/07

AZT Can Cause Severe Anemia and Necessitate Ribavirin Dose Reduction in HIV-HCV Coinfected Patients
  4/22/07

Nodular Regenerative Hyperplasia as a Cause of Chronic Liver Disease in HIV Positive Individuals   - 2/09/07

Stavudine, Lamivudine and Nevirapine Is Maintained Longer than Other First-line Regimens in a Large Asian Cohort
 1/19/07

Gene Variation Associated with Tenofovir Kidney Toxicity  1/19/07

Severe Stress, Anxiety and Unusual Dreams May Reflect Persistent Central Nervous Toxicity of Efavirenz
 1/19/07

Risk Factors for Kidney Toxicity in Patients Taking Tenofovir   12/01/06

FDA Issues Safety Warning on Erythropoietin   12/01/06

Liposomal Daunorubicin for the Treatment of Kaposi's Sarcoma
- 8/29/06

Anal Cancer Rates Increase Dramatically in the HAART Era
 - 8/22/06

Growth Factors for Neutropenia and Anemia Effective in Coinfected Patients 5/20/06

Landmark Discovery of a Kaposi's Sarcoma-associated Herpesvirus Receptor Provides New Perspectives on Disease Associated with HIV/AIDS - 4/11/06

Treatment of HIV-associated Kaposi's Sarcoma with Pegylated Liposomal Doxorubicin and HAART Produces Tumor Remission and CD4+ T Cell Recovery - 10/26/05


Clinical Response of AIDS-associated Kaposi's Sarcoma to HAART - 10/26/05

Recurrence of Kaposi's Sarcoma after Initiation of HAART: A Manifestation of Immune Reconstitution Syndrome - 10/24/05

Hydroxychloroquine, Hydroxyurea and Didanosine as Initial Therapy for HIV Patients with Low Viral Load: A Useful Strategy for Delaying HAART?
- 2/09/05

Immunological Analysis of Pediatric Patients at Different Stages of HIV Disease
- 1/26/05

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Protease Inhibitors (PIs)
Note: Most PIs are now used in combination with low-dose ritonavir (Norvir)
Agenerase
Agenerase (amprenavir)
Aptivus
Aptivus (tipranavir)
Crixivan
Crixivan (indinavir)
Invirase
Invirase (saquinavir )
Kaletra
Kaletra (lopinavir/ritonavir)
Lexiva
Lexiva (fosamprenavir)
Norvir
Norvir (ritonavir)
Prezista
Prezista (darunavir)
Reyataz
Reyataz (atazanavir)
Viracept
Viracept (nelfinavir)
Nucleoside / Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
Combivir
Combivir (zidovudine + lamivudine)
Epivir
Epivir (lamivudine; 3TC)
Emtriva
Emtriva (emtricitabine; FTC)
Epzicom
Epzicom (abacavir + lamivudine)
Retrovir
Retrovir (zidovudine; AZT)
Trizivir
Trizivir (abacavir + zidovudine +lamivudine)
Truvada
Truvada  (tenofovir + emtricitabine)
Videx
Videx (didanosine; ddI)
Viread
Viread (tenofovir)
Zerit
Zerit (stavudine; d4T)
Ziagen
Ziagen (abacavir)
non Nucleoside Reverse
Transcriptase  Inhibitors
(nNRTIs)
Rescriptor
Intelence (etravirine)
Rescriptor
Rescriptor (delavirdine)
Sustiva
Sustiva (efavirenz)
Viramune
Viramune (nevirapine)
Entry / Fusion Inhibitors
Fuzeon (enfuvirtide)
Selzentry/Celsentri ( maraviroc)
Fixed-dose Combinations
Atripla
Atripla (efavirenz + emtricitabine + tenofovir)
Combivir
Combivir (zidovudine + lamivudine)
Trizivir
Trizivir (abacavir + zidovudine + lamivudine)
Truvada
Truvada (tenofovir + emtricitabine)
Integrase Inhibitors
Isentress (raltegravir)